We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+26.51%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$2.28B
AUM Growth
+$663M
Cap. Flow
+$192M
Cap. Flow %
8.42%
Top 10 Hldgs %
37.08%
Holding
98
New
19
Increased
31
Reduced
23
Closed
19

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$56.8M
2
BIIB icon
Biogen
BIIB
+$47.5M
3
UNH icon
UnitedHealth
UNH
+$32.1M
4
LNTH icon
Lantheus
LNTH
+$30.4M
5
AZO icon
AutoZone
AZO
+$29.5M

Top Sells

Rank Stock Value
1
VXRT
Vaxart
VXRT
+$72M
2
DECK icon
Deckers Outdoor
DECK
+$30.5M
3
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$29.6M
4
AMZN icon
Amazon
AMZN
+$25.4M
5
DLTR icon
Dollar Tree
DLTR
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 45.31%
2 Consumer Discretionary 15.79%
3 Consumer Staples 9.9%
4 Technology 5.31%
5 Industrials 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$31.1M 1.36%
272,000
-40,000
-13% -$3.88M
BBY icon
27
Best Buy
BBY
$18.2B
$29M 1.27%
+331,919
New +$25.2M
CPRX
28
DELISTED
Catalyst Pharmaceutical
CPRX
$28.6M 1.26%
6,200,000
+800,000
+15% +$3.59M
BURL icon
29
Burlington
BURL
$23.2B
$28.6M 1.26%
145,364
-112,640
-44% -$21.2M
MDGL icon
30
Madrigal Pharmaceuticals
MDGL
$10.8B
$28.1M 1.23%
248,000
+32,000
+15% +$3.15M
ZYME icon
31
Zymeworks
ZYME
$1.61B
$28.1M 1.23%
+778,000
New +$28.7M
MRK icon
32
Merck
MRK
$322B
$27.8M 1.22%
377,280
+62,880
+20% +$4.73M
TWNK
33
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$27.8M 1.22%
2,278,000
+1,278,000
+128% +$15.1M
CL icon
34
Colgate-Palmolive
CL
$73.1B
$27M 1.18%
368,000
+188,000
+104% +$13.4M
FTDR icon
35
Frontdoor
FTDR
$5.1B
$26.2M 1.15%
592,000
-48,000
-8% -$1.96M
VYGR icon
36
Voyager Therapeutics
VYGR
$183M
$26.2M 1.15%
2,078,000
-158,000
-7% -$1.84M
KHC icon
37
Kraft Heinz
KHC
$30.7B
$25.5M 1.12%
800,000
-400,000
-33% -$12M
PTCT icon
38
PTC Therapeutics
PTCT
$5.68B
$25.4M 1.11%
500,000
-100,000
-17% -$4.91M
CMG icon
39
Chipotle Mexican Grill
CMG
$47.2B
$25.3M 1.11%
1,200,000
+360,050
+43% +$6.67M
FL
40
DELISTED
Foot Locker
FL
$23.8M 1.04%
+814,740
New +$21.5M
AVTA
41
DELISTED
Avantax, Inc. Common Stock
AVTA
$23.4M 1.03%
+2,048,000
New +$25.7M
UBER icon
42
Uber
UBER
$143B
$22.9M 1%
736,000
+464,000
+171% +$14.5M
AVYA
43
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
$22.7M 1%
1,836,000
+244,000
+15% +$2.81M
MDLZ icon
44
Mondelez International
MDLZ
$79.5B
$21.9M 0.96%
428,000
+128,000
+43% +$6.58M
KFY icon
45
Korn Ferry
KFY
$4.18B
$21.9M 0.96%
712,000
+562,000
+375% +$16.1M
EPC icon
46
Edgewell Personal Care
EPC
$1.25B
$21.8M 0.96%
700,000
-100,000
-13% -$2.8M
CPB icon
47
Campbell Soup
CPB
$6.55B
$21.6M 0.95%
436,000
-42,000
-9% -$2.09M
SMAR
48
DELISTED
Smartsheet Inc.
SMAR
$21.2M 0.93%
416,000
+308,000
+285% +$15.7M
LOW icon
49
Lowe's Companies
LOW
$117B
$18.3M 0.8%
135,416
+26,177
+24% +$2.99M
ENTA icon
50
Enanta Pharmaceuticals
ENTA
$366M
$16.3M 0.71%
324,000
-244,000
-43% -$12.6M
1
2
3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q2 2020 Portfolio in Review

As of Q2 2020, Armistice Capital held 98 positions worth $2.28B, up 41% from $1.62B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Armistice Capital deployed $192M of net new capital in Q2 2020, opening 19 new positions and adding to 31 existing holdings. Its largest new stake was Medtronic: 592,000 shares worth $54.3M.

By sector, the portfolio is most concentrated in Healthcare at 45% of assets, down from 47% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Vaxart, an estimated $72M trimmed.

  • Armistice Capital's largest Q2 2020 buy was Medtronic: 592,000 shares worth $54.3M.
  • Armistice Capital added most to Biogen in Q2 2020, an estimated $47.5M increase.
  • Armistice Capital's biggest Q2 2020 reduction was Vaxart, cutting an estimated $72M.
  • Armistice Capital fully exited Deckers Outdoor in Q2 2020, selling an estimated $30.5M.
  • Armistice Capital's ten largest holdings make up 37% of its $2.28B portfolio in Q2 2020.
  • Armistice Capital opened 19 new positions and closed 19 in Q2 2020.
  • Armistice Capital's portfolio value rose 41% quarter-over-quarter to $2.28B.

Based on Armistice Capital's 13F filing for Q2 2020, filed 14 Aug 2020.